-
公开(公告)号:US08637274B2
公开(公告)日:2014-01-28
申请号:US12606792
申请日:2009-10-27
申请人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
发明人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
IPC分类号: C12N15/09
CPC分类号: A61K31/22 , A61K31/366 , A61K31/401 , G01N2333/96425 , G01N2800/2821
摘要: It is intended to provide an inhibitor for the formation of a γ-secretase complex which comprises a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator as the active ingredient; and use of a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator for producing the same. It is also intended to provide a method of screening a substance having an effect of inhibiting the formation of an active complex of γ-secretase which comprises assaying the activity of inhibiting cholesterol synthesis or quantifying cholesterol accumulated in lipid rafts in cells. It is also intended to provide a method of screening a cholesterol synthesis inhibitor, a protein geranylgeranylation regulator or an HMG-CoA reductase inhibitor which comprises assaying the effect of inhibiting the formation of an active complex of γ-secretase. Moreover, it is intended to provide a method of screening an effect of a test substance on γ-secretase which comprises measuring the distribution of constituents (niscastrin, APH-1, Pen-2 and so on) required by γ-secretase for the formation of its active complex in cells.
摘要翻译: 旨在提供用于形成γ-分泌酶复合物的抑制剂,其包含胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂作为活性成分; 以及使用胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂来制备它们。 还旨在提供一种筛选具有抑制γ-分泌酶活性复合物形成的作用的物质的方法,其包括测定抑制胆固醇合成的活性或定量细胞中脂质筏中累积的胆固醇。 还旨在提供一种筛选胆固醇合成抑制剂,蛋白质香叶基香叶基调节剂或HMG-CoA还原酶抑制剂的方法,其包括测定抑制γ-分泌酶活性复合物形成的作用。 此外,旨在提供一种筛选测试物质对γ-分泌酶的作用的方法,其包括测量γ-分泌酶对于形成所需的成分(脑膜炎,APH-1,Pen-2等)的分布 其活性复合物在细胞中。
-
公开(公告)号:US20100093010A1
公开(公告)日:2010-04-15
申请号:US12606792
申请日:2009-10-27
申请人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
发明人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
CPC分类号: A61K31/22 , A61K31/366 , A61K31/401 , G01N2333/96425 , G01N2800/2821
摘要: It is intended to provide an inhibitor for the formation of a γ-secretase complex which comprises a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator as the active ingredient; and use of a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator for producing the same. It is also intended to provide a method of screening a substance having an effect of inhibiting the formation of an active complex of γ-secretase which comprises assaying the activity of inhibiting cholesterol synthesis or quantifying cholesterol accumulated in lipid rafts in cells. It is also intended to provide a method of screening a cholesterol synthesis inhibitor, a protein geranylgeranylation regulator or an HMG-CoA reductase inhibitor which comprises assaying the effect of inhibiting the formation of an active complex of γ-secretase. Moreover, it is intended to provide a method of screening an effect of a test substance on γ-secretase which comprises measuring the distribution of constituents (niscastrin, APH-1, Pen-2 and so on) required by γ-secretase for the formation of its active complex in cells.
摘要翻译: 旨在提供用于形成γ-分泌酶复合物的抑制剂,其包含胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂作为活性成分; 以及使用胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂来制备它们。 本发明还提供一种筛选具有抑制γ-分泌酶活性复合物形成的作用的物质的方法,该方法包括测定抑制胆固醇合成的活性或量化在细胞中积累的脂筏中的胆固醇。 本发明还旨在提供一种筛选胆固醇合成抑制剂,蛋白er牛儿基胆碱化调节剂或HMG-CoA还原酶抑制剂的方法,其包括测定抑制γ-分泌酶活性复合物形成的作用。 此外,旨在提供一种筛选测试物质对γ分泌酶的作用的方法,其包括测量γ-分泌酶对于形成所需的成分(脑膜炎,APH-1,Pen-2等)的分布 其活性复合物在细胞中。
-
公开(公告)号:US08394376B2
公开(公告)日:2013-03-12
申请号:US12962019
申请日:2010-12-07
申请人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
发明人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
IPC分类号: A61K39/395
CPC分类号: G01N33/6896 , A61K2039/505 , C07K16/40 , C07K2317/73 , C07K2317/76 , G01N33/574 , G01N2333/948 , G01N2500/02
摘要: To provide a therapeutic drug for Alzheimer's disease and/or a cancer. The therapeutic drug for Alzheimer's disease and/or a cancer contains an anti-nicastrin antibody, a derivative of the antibody, or a fragment of the antibody or the derivative.
-
公开(公告)号:US08398981B2
公开(公告)日:2013-03-19
申请号:US13276501
申请日:2011-10-19
申请人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
发明人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
IPC分类号: A61K39/395
CPC分类号: G01N33/6896 , A61K2039/505 , C07K16/40 , C07K2317/73 , C07K2317/76 , G01N33/574 , G01N2333/948 , G01N2500/02
摘要: To provide a therapeutic drug for Alzheimer's disease and/or a cancer. The therapeutic drug for Alzheimer's disease and/or a cancer contains an anti-nicastrin antibody, a derivative of the antibody, or a fragment of the antibody or the derivative.
摘要翻译: 为阿尔茨海默病和/或癌症提供治疗药物。 用于阿尔茨海默氏病和/或癌症的治疗药物含有抗 - 尼卡星抗体,抗体衍生物或抗体或其衍生物的片段。
-
公开(公告)号:US20110165179A1
公开(公告)日:2011-07-07
申请号:US12962019
申请日:2010-12-07
申请人: Takeshi IWATSUBO , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
发明人: Takeshi IWATSUBO , Tatsuhiko Kodama , Takao Hamakubo , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
IPC分类号: A61K39/395 , A61P25/28 , A61P35/00 , A61P35/02
CPC分类号: G01N33/6896 , A61K2039/505 , C07K16/40 , C07K2317/73 , C07K2317/76 , G01N33/574 , G01N2333/948 , G01N2500/02
摘要: To provide a therapeutic drug for Alzheimer's disease and/or a cancer.The therapeutic drug for Alzheimer's disease and/or a cancer contains an anti-nicastrin antibody, a derivative of the antibody, or a fragment of the antibody or the derivative.
摘要翻译: 为阿尔茨海默病和/或癌症提供治疗药物。 用于阿尔茨海默氏病和/或癌症的治疗药物含有抗 - 尼卡星抗体,抗体衍生物或抗体或其衍生物的片段。
-
公开(公告)号:US20070161700A1
公开(公告)日:2007-07-12
申请号:US10584415
申请日:2004-12-28
申请人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
发明人: Yasuomi Urano , Takao Hamakubo , Tatsuhiko Kodama
IPC分类号: A61K31/401 , A61K31/366 , A61K31/22
CPC分类号: A61K31/22 , A61K31/366 , A61K31/401 , G01N2333/96425 , G01N2800/2821
摘要: It is intended to provide an inhibitor for the formation of a γ-secretase complex which comprises a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator as the active ingredient; and use of a cholesterol synthesis inhibitor or a protein geranylgeranylation regulator for producing the same. It is also intended to provide a method of screening a substance having an effect of inhibiting the formation of an active complex of γ-secretase which comprises assaying the activity of inhibiting cholesterol synthesis or quantifying cholesterol accumulated in lipid rafts in cells. It is also intended to provide a method of screening a cholesterol synthesis inhibitor, a protein geranylgeranylation regulator or an HMG-CoA reductase inhibitor which comprises assaying the effect of inhibiting the formation of an active complex of γ-secretase. Moreover, it is intended to provide a method of screening an effect of a test substance on γ-secretase which comprises measuring the distribution of constituents (niscastrin, APH-1, Pen-2 and so on) required by γ-secretase for the formation of its active complex in cells.
摘要翻译: 旨在提供用于形成γ-分泌酶复合物的抑制剂,其包含胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂作为活性成分; 以及使用胆固醇合成抑制剂或蛋白质香叶基香叶基化调节剂来制备它们。 还旨在提供一种筛选具有抑制γ-分泌酶活性复合物形成的作用的物质的方法,其包括测定抑制胆固醇合成的活性或定量细胞中脂质筏中累积的胆固醇。 还旨在提供一种筛选胆固醇合成抑制剂,蛋白质香叶基香叶基调节剂或HMG-CoA还原酶抑制剂的方法,其包括测定抑制γ-分泌酶活性复合物形成的作用。 此外,旨在提供一种筛选测试物质对γ-分泌酶的作用的方法,其包括测量γ-分泌酶对于形成所需的成分(脑膜炎,APH-1,Pen-2等)的分布 其活性复合物在细胞中。
-
公开(公告)号:US20090220524A1
公开(公告)日:2009-09-03
申请号:US12298151
申请日:2007-04-23
申请人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakuob , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
发明人: Takeshi Iwatsubo , Tatsuhiko Kodama , Takao Hamakuob , Taisuke Tomita , Ikuo Hayashi , Yasuomi Urano , Hiroko Iwanari , Masao Ohkuchi
IPC分类号: A61K39/395 , C07K16/18 , G01N33/573
CPC分类号: G01N33/6896 , A61K2039/505 , C07K16/40 , C07K2317/73 , C07K2317/76 , G01N33/574 , G01N2333/948 , G01N2500/02
摘要: To provide a therapeutic drug for Alzheimer's disease and/or a cancer.The therapeutic drug for Alzheimer's disease and/or a cancer contains an anti-nicastrin antibody, a derivative of the antibody, or a fragment of the antibody or the derivative.
摘要翻译: 为阿尔茨海默病和/或癌症提供治疗药物。 用于阿尔茨海默氏病和/或癌症的治疗药物含有抗 - 尼卡星抗体,抗体衍生物或抗体或其衍生物的片段。
-
公开(公告)号:US20080161348A1
公开(公告)日:2008-07-03
申请号:US11694288
申请日:2007-03-30
IPC分类号: A61K31/695 , A61K31/47
CPC分类号: A61K31/404 , A61K31/22 , A61K31/365 , A61K31/40
摘要: A method for suppressing expression of PTX3 gene, which comprises administering an effective amount of a compound, which is represented by the following formula (1): wherein R1 represents an organic group, X represents —CH2CH2— or —CH═CH—, and R2 represents a hydrogen atom or an alkyl group, or a lactone derivative thereof, or a salt thereof.According to the present invention, a PTX3 gene expression suppressing method useful for the treatment of autoimmune diseases, especially rheumatoid arthritis can be provided.
摘要翻译: 一种抑制PTX3基因表达的方法,其包括给予有效量的由下式(1)表示的化合物:其中R 1表示有机基团,X表示-CH 2或2-CH 2 - 或-CH-CH-,R 2表示氢原子或烷基或其内酯衍生物, 或其盐。 根据本发明,可以提供用于治疗自身免疫性疾病,特别是类风湿性关节炎的PTX3基因表达抑制方法。
-
公开(公告)号:US06602710B1
公开(公告)日:2003-08-05
申请号:US09141371
申请日:1998-08-27
IPC分类号: C12Q100
CPC分类号: G01N33/5041 , C12Q1/6897 , G01N33/5008 , G01N33/502 , G01N33/92 , G01N2500/00 , G01N2800/044
摘要: This invention provides a screening method for sterol regulatory element binding protein (SREBP) pathway-specific inhibitors using a mutant cultured cell, as well as therapeutic agents for hyperlipemia, arterial sclerosis, obesity or cancer containing an SREBP pathway-specific inhibitor selected by said screening method.
摘要翻译: 本发明提供使用突变培养细胞的甾醇调节元件结合蛋白(SREBP)途径特异性抑制剂的筛选方法,以及含有通过所述筛选法选择的SREBP途径特异性抑制剂的高脂血症,动脉硬化症,肥胖症或癌症的治疗剂 方法。
-
公开(公告)号:US20100062449A1
公开(公告)日:2010-03-11
申请号:US12092272
申请日:2006-11-10
申请人: Tatsuhiko Kodama , Takao Hamakubo , Koji Maemura , Akira Sugiyama , Hiroko Iwanari , Isao Kohno , Yukio Ito
发明人: Tatsuhiko Kodama , Takao Hamakubo , Koji Maemura , Akira Sugiyama , Hiroko Iwanari , Isao Kohno , Yukio Ito
CPC分类号: C07K16/18 , G01N33/577 , G01N33/6893 , G01N2800/324 , Y10S435/81
摘要: To provide a method of determining vasculopathy, which is a risk factor of myocardial infarction, angiopathic dementia, etc., at an early stage thereof (i.e., mild vasculopathy). The present invention provides a method of determining the severity of mild vasculopathy, including determining PTX3 level in an assay sample by use of an anti-PTX3 monoclonal antibody.
摘要翻译: 提供一种在早期阶段(即轻度血管病变)来确定血管病变的方法,血管病变是心肌梗死,血管性痴呆等的危险因素。 本发明提供了一种确定轻度血管病变的严重性的方法,包括通过使用抗PTX3单克隆抗体测定测定样品中的PTX3水平。
-
-
-
-
-
-
-
-
-